2019
DOI: 10.1007/978-3-030-23261-0_7
|View full text |Cite
|
Sign up to set email alerts
|

Methanobactin: A Novel Copper-Binding Compound Produced by Methanotrophs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 152 publications
0
2
0
Order By: Relevance
“…Methanobactins (Mbns) are peptide chalkophores that bind copper, which is needed for cell synthesis [79]. They were originally characterized in the methanotrophic bacterial species Methylococcus capsulatus and were found to be required for the functioning of methane oxidizing pMMO [68], which is transported outside of the cell to trap and bind to Cu(I) ions [80]. This chelating effect also reduces Cu(II), which is toxic to the bacterial cell, and to Cu(I) in copper-deficient environments [81,82].…”
Section: Methanobactinmentioning
confidence: 99%
See 1 more Smart Citation
“…Methanobactins (Mbns) are peptide chalkophores that bind copper, which is needed for cell synthesis [79]. They were originally characterized in the methanotrophic bacterial species Methylococcus capsulatus and were found to be required for the functioning of methane oxidizing pMMO [68], which is transported outside of the cell to trap and bind to Cu(I) ions [80]. This chelating effect also reduces Cu(II), which is toxic to the bacterial cell, and to Cu(I) in copper-deficient environments [81,82].…”
Section: Methanobactinmentioning
confidence: 99%
“…This is especially important as the ability of reducing gold has successfully generated gold nanoparticles that have many biomedical applications. These applications include antimicrobial activity, incorporation in fuel cells, photo-thermal and dynamic therapy, cancer treatment, act as an epitope, and tether to immunogenic molecules that have the ability to attach to cancer biomarkers (antigens), and in the development of many medically advanced technologies such as plasmonic biosensors, for visualization, and bioimaging [80]. Mbns also show great potential in the treatment of copper-associated illnesses such as Wilson disease (WD), Alzheimer disease (AD), fatty liver disease, and BRAF-positive cancers by preventing copper buildup in the liver and consequently other body tissues, and thereby preventing permanent liver and neurological tissue damage [83].…”
Section: Methanobactinmentioning
confidence: 99%